VIVOS THERAPEUTICS INC (VVOS) Stock Analyst Ratings
USA - NASDAQ:VVOS - US92859E2072 - Common Stock
2.57 USD
+0.25 (+10.78%)
2.5 USD
-0.07 (-2.72%)
ChartMill assigns a Buy % Consensus number of 80% to VVOS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.36. This target is 108.37% above the current price.
VVOS was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VVOS.
In the previous month the buy percentage consensus was at a similar level.
VVOS was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-15 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-11-20 | Ascendiant Capital | Reiterate | Buy -> Buy |
| 2024-11-19 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2024-08-20 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-01-17 | Ascendiant Capital | Initiate | Buy |
| 2021-08-13 | Roth Capital | Maintains | Buy |
| 2021-05-18 | Roth Capital | Maintains | Buy |
VIVOS THERAPEUTICS INC / VVOS FAQ
What is the average price target for VIVOS THERAPEUTICS INC (VVOS) stock?
8 analysts have analysed VVOS and the average price target is 5.36 USD. This implies a price increase of 108.37% is expected in the next year compared to the current price of 2.57.
What is the consensus rating for VVOS stock?
The consensus rating for VIVOS THERAPEUTICS INC (VVOS) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover VIVOS THERAPEUTICS INC (VVOS) stock?
The number of analysts covering VIVOS THERAPEUTICS INC (VVOS) is 8.